Analysis of the clinical data revealed that participants in the PSP group had higher plasma CRP levels (1.59 mg/L vs. 0.84 mg/L, p < 0.001) (n = 56 vs. n = 56) (Figure 2C and Table 3), which suggests a systemic inflammatory response in patients with PSP. This evidence concerns the gene CRP and supranuclear palsy, progressive, 1.